JPS59130862A - 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体、それらの製造方法及び抗菌剤 - Google Patents

窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体、それらの製造方法及び抗菌剤

Info

Publication number
JPS59130862A
JPS59130862A JP59001419A JP141984A JPS59130862A JP S59130862 A JPS59130862 A JP S59130862A JP 59001419 A JP59001419 A JP 59001419A JP 141984 A JP141984 A JP 141984A JP S59130862 A JPS59130862 A JP S59130862A
Authority
JP
Japan
Prior art keywords
group
compound
radical
formula
radicals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59001419A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0480912B2 (enExample
Inventor
ジヤン・ジヨルジユ・トウ−チ
ミシエル・クリク
ジヤン・フランソワ・シヤント
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS59130862A publication Critical patent/JPS59130862A/ja
Publication of JPH0480912B2 publication Critical patent/JPH0480912B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP59001419A 1983-01-10 1984-01-10 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体、それらの製造方法及び抗菌剤 Granted JPS59130862A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8300273A FR2539128A1 (fr) 1983-01-10 1983-01-10 Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
FR8300273 1983-01-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2288631A Division JPH0678336B2 (ja) 1983-01-10 1990-10-29 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体及びそれらの製造方法

Publications (2)

Publication Number Publication Date
JPS59130862A true JPS59130862A (ja) 1984-07-27
JPH0480912B2 JPH0480912B2 (enExample) 1992-12-21

Family

ID=9284799

Family Applications (2)

Application Number Title Priority Date Filing Date
JP59001419A Granted JPS59130862A (ja) 1983-01-10 1984-01-10 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体、それらの製造方法及び抗菌剤
JP2288631A Expired - Lifetime JPH0678336B2 (ja) 1983-01-10 1990-10-29 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体及びそれらの製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2288631A Expired - Lifetime JPH0678336B2 (ja) 1983-01-10 1990-10-29 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体及びそれらの製造方法

Country Status (11)

Country Link
EP (1) EP0114128B1 (enExample)
JP (2) JPS59130862A (enExample)
AT (1) ATE41661T1 (enExample)
CA (1) CA1244034A (enExample)
DE (1) DE3477382D1 (enExample)
DK (1) DK164404C (enExample)
ES (1) ES528742A0 (enExample)
FR (1) FR2539128A1 (enExample)
GR (1) GR79459B (enExample)
IE (1) IE56521B1 (enExample)
PT (1) PT77939B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6013787A (ja) * 1983-07-04 1985-01-24 Toyama Chem Co Ltd 新規なアゼチジノン誘導体およびその塩類
JPS6110581A (ja) * 1984-06-25 1986-01-18 Toyama Chem Co Ltd 新規なアゼチジノン誘導体およびその塩
JPS61271288A (ja) * 1985-05-22 1986-12-01 ルセル−ニクラフ 解裂性有機基置換テトラゾリル基を1位置に有する3−アミノ−2−オキソアゼチジンの新誘導体、それらの製造方法及び薬剤としての応用
JPH06172354A (ja) * 1984-06-25 1994-06-21 Toyama Chem Co Ltd 新規なアゼチジノン誘導体またはその塩

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581180B2 (en) * 1983-08-26 1989-02-16 E.R. Squibb & Sons, Inc. 1-(1h-tetrazol-5-ylalkoxy)-2-azetidinones
FR2585021B2 (fr) * 1985-07-18 1989-05-19 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidinone comportant, en position 1, un radical heterocyclique azote, leur procede de preparation et leur application comme medicaments
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
KR890700588A (ko) * 1987-02-11 1989-04-25 로버어트 에이 아미테이지 항생 물질로서 신규 N-1 치환된 β -락탐
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
EP0300636A1 (en) * 1987-07-22 1989-01-25 The Upjohn Company Therapeutically useful beta-lactams
CN103012316B (zh) * 2012-11-29 2015-03-25 浙江工业大学 N-4-甲基-1,2,3-噻二唑-4-酰基-n-取代1,3,4-噻二唑基硫脲衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468874A (en) * 1967-04-10 1969-09-23 R & L Molecular Research Ltd 6 - tetrazolylacetamido penicillanic and 7-tetrazolylacetamido cephalosporanic acids
US4186131A (en) * 1977-04-21 1980-01-29 Mead Johnson & Company Phenyltetrazolyloxy propanolamines
DE2946432A1 (de) * 1979-11-17 1981-06-11 Bayer Ag, 5090 Leverkusen Tetrazolyloxycarbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6013787A (ja) * 1983-07-04 1985-01-24 Toyama Chem Co Ltd 新規なアゼチジノン誘導体およびその塩類
JPS6110581A (ja) * 1984-06-25 1986-01-18 Toyama Chem Co Ltd 新規なアゼチジノン誘導体およびその塩
JPH06172354A (ja) * 1984-06-25 1994-06-21 Toyama Chem Co Ltd 新規なアゼチジノン誘導体またはその塩
JPS61271288A (ja) * 1985-05-22 1986-12-01 ルセル−ニクラフ 解裂性有機基置換テトラゾリル基を1位置に有する3−アミノ−2−オキソアゼチジンの新誘導体、それらの製造方法及び薬剤としての応用

Also Published As

Publication number Publication date
JPH0678336B2 (ja) 1994-10-05
IE56521B1 (en) 1991-08-28
CA1244034A (fr) 1988-11-01
GR79459B (enExample) 1984-10-30
EP0114128A1 (fr) 1984-07-25
FR2539128B1 (enExample) 1985-05-03
JPH03163076A (ja) 1991-07-15
PT77939A (fr) 1984-02-01
DK7584D0 (da) 1984-01-09
JPH0480912B2 (enExample) 1992-12-21
DE3477382D1 (en) 1989-04-27
PT77939B (fr) 1986-06-18
DK164404C (da) 1992-11-09
FR2539128A1 (fr) 1984-07-13
ES8407046A1 (es) 1984-08-16
IE840036L (en) 1984-07-10
EP0114128B1 (fr) 1989-03-22
DK7584A (da) 1984-07-11
ES528742A0 (es) 1984-08-16
ATE41661T1 (de) 1989-04-15
DK164404B (da) 1992-06-22

Similar Documents

Publication Publication Date Title
US5326776A (en) Angiotensin II receptor antagonists
EP0053816B1 (en) 1-sulfo-2-oxoazetidine derivatives, their production and use
CA2637024C (en) Substituted imidazole derivatives, compositions, and methods of use as ptpase inhibitors
JPS59130862A (ja) 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体、それらの製造方法及び抗菌剤
JPH0196181A (ja) 2−オキソ−1−[[(置換スルホニル)アミノ]カルボニル]アゼチジン類
DE2710902A1 (de) Cephemderivate und verfahren zu ihrer herstellung
CA1224784A (en) Amide derivatives of 2-oxo-1-azetidinesulphonic acids
LU86611A1 (fr) 2-oxo-1-(((sulfonyl substitute)amino) -carbonyl) azetidines
SE461655B (sv) 3-amino-2-oxo-azetidin-1-sulfonsyraderivat, saett foer framstaellning daerav samt naemnda derivat till anvaendning som laekemedel
DD213919A5 (de) Verfahren zur herstellung von beta-lactam derivaten
FR2472574A1 (fr) Derives de cephalosporine et composition pharmaceutique les contenant
JPS58121269A (ja) アゼチジン類
DE69507887T2 (de) Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
JPS635075A (ja) 2−オキソ−1−〔〔(置換スルホニル)アミノ〕カルボニル〕アゼチジン類
EP2254893A1 (fr) Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
JPH07157459A (ja) ビフェニルメチル置換バレリルアミド誘導体
CH654297A5 (fr) 2-oxo-azetidines.
AU598199B2 (en) Oxyimino penicillins
JPH02284A (ja) 2―オキソ―1―[[(置換スルホニル)アミノ]カルボニル]アゼチジン類の製造法および該方法に用いる中間体
DE2908033A1 (de) Neue cephalosporinverbindungen, verfahren zur herstellung derselben und solche wirksubstanzen enthaltende therapeutische praeparate
JPH0255435B2 (enExample)
CH668072A5 (fr) Derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical tetrazolyle substitue par un radical organique clivable, procedes pour leur preparation et les compositions les renfermant.
JPH0340028B2 (enExample)
FR2506307A1 (fr) Nouveaux derives substitues de l'acide 2-(2-amino 4-thiazolyl) 2-hydroxyimino acetique et leur procede de preparation
KR19990022836A (ko) 테트라졸릴화 비페닐메탄 유도체의 제조방법